This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Walter and Eliza Hall Institute of Medical Research. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: George K Chandy: Innovator in Therapeutic Ion Channel Modulation
Introduction
George K Chandy is a notable inventor based in Irvine, California. He has made significant contributions to the field of medical research, particularly in the development of therapeutic agents that target ion channels. His work has implications for treating autoimmune and inflammatory diseases.
Latest Patents
Chandy holds a patent for "Therapeutic ion channel blocking agents and methods of use thereof." This patent describes various divalent ligands based on khellinone derivatives. These derivatives are useful in modulating potassium channel activity in cells, specifically Kv1.3 channels found in T-cells. The compounds developed may also aid in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis.
Career Highlights
Throughout his career, George K Chandy has worked with prestigious institutions such as the Walter and Eliza Hall Institute of Medical Research and the University of California. His research has focused on the intersection of ion channel biology and therapeutic applications, showcasing his commitment to advancing medical science.
Collaborations
Chandy has collaborated with notable researchers, including Jonathan Bayldon Baell and Heike Wulff. Their combined expertise has contributed to the advancement of knowledge in the field of ion channel modulation.
Conclusion
George K Chandy's innovative work in therapeutic ion channel modulation highlights his significant contributions to medical research. His patent and collaborations reflect a dedication to improving treatments for autoimmune and inflammatory diseases.